This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Drug Therapy, Other  • Alert me on articles by topic

James R. Johnson, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The study by Hidayat et al¹ raises more questions than it answers and fails to directly support the authors' main conclusions. "Target trough" is not explicitly defined in the "Methods" section: does it mean greater than or equal to 4 times the MIC of the infecting strain or 15 µg/mL or greater? "Corrected trough" (Table 3¹) also is undefined. It is unclear whether attainment of target trough was assessed based on the corrected or uncorrected trough and whether such attainment was assessed separately for the initial response (Figure 1, first 72 hours only¹) and the final response (Figure 2, total treatment course¹). Because the final outcome of therapy was not significantly associated (and initial response was only marginally associated) with achievement of target trough and outcomes seemingly were not analyzed in relation to achievement of troughs 15 µg/mL or greater, the basis for . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections: Efficacy and Toxicity
Levita K. Hidayat, Donald I. Hsu, Ryan Quist, Kimberly A. Shriner, and Annie Wong-Beringer
Arch Intern Med. 2006;166(19):2138-2144.
ABSTRACT | FULL TEXT